Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATR | Q13535 | 4/20 | 0.40 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.34 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.34 |
| ▸ | BRD4 | O60885 | 9/20 | 0.34 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.32 |
| ▸ | TLR2 | O60603 | 1/20 | 0.31 |
| ▸ | TLR1 | Q15399 | 1/20 | 0.31 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.31 |
| ▸ | MIF | P14174 | 1/20 | 0.31 |
| ▸ | ATRIP | Q8WXE1 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27376667 | 0.89 | ATR (0.41) | ATRPRMT5WDR77BRD4USP30 | |
| SCHEMBL30797747 | 0.89 | ATR (0.41) | ATRPRMT5WDR77BRD4USP30 | |
| SCHEMBL30869132 | 0.89 | ATR (0.44) | ATRPRMT5WDR77BRD4USP30 | |
| SCHEMBL30869065 | 0.86 | ATR (0.42) | ATRBRD4TLR2TLR1ATRIP | |
| SCHEMBL30869111 | 0.83 | ATR (0.41) | ATRBRD4TLR2TLR1ATRIP | |
| SCHEMBL30869064 | 0.81 | ATR (0.41) | ATRBRD4TLR2TLR1MIF | |
| SCHEMBL30868992 | 0.81 | ATR (0.42) | ATRBRD4TLR2TLR1MIF | |
| SCHEMBL30797881 | 0.81 | ATR (0.47) | ATRPRMT5WDR77BRD4USP30 | |
| SCHEMBL30869047 | 0.79 | ATR (0.33) | ATRPRMT5WDR77USP30 | |
| SCHEMBL30869097 | 0.75 | ATR (0.47) | ATRBRD4ATRIP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4584249-A1 | NOVEL COMPOUNDS AS CK2 INHIBITORS | Cambridge Enterprise Limited (GB) | 2025-07-16 | — | — | EP | disclosed |
| WO-2024052702-A1 | NOVEL COMPOUNDS AS CK2 INHIBITORS | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2024-03-14 | — | — | WO | disclosed |